Salivary gland carcinomas are a heterogeneous group of tumors that comprise about 5-10% of all oropharyngeal cancers. Tumor classification and stage have a significant impact on patient survival. Primary treatment of salivary gland carcinomas is surgical resection in combination with postoperative radiotherapy and/or chemotherapies when required. Molecular abnormalities as potential therapeutic targets differ between certain tumor types.
CITATION STYLE
Wolf, A. (2017). Parotid cancer. In Mechanisms of Molecular Carcinogenesis (Vol. 1, pp. 199–204). Springer International Publishing. https://doi.org/10.1007/978-3-319-53659-0_13
Mendeley helps you to discover research relevant for your work.